Inhibitors of TGF-R signaling for treatment of CNS disorders

Details for Australian Patent Application No. 2005210151 (hide)

Owner Regenion GmbH

Inventors Wachs, Frank Peter; Winkler, Jurgen; Aigner, Ludwig; Bogdahn, Ulrich; Winner, Beate

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005210151

PCT Pub. Number WO2005/074981

Priority 04002846.6 09.02.04 EP

Filing date 9 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 1 July 2010

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074981 Priority application(s): WO2005/074981

1 July 2010 Application Accepted

  Published as AU-B-2005210151

5 August 2010 Assignment before Grant

  Regenion GmbH The application has been assigned to Aigner, Ludwig; Bogdahn, Ulrich

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210155-Spool and spool assembly for windingup carrier tapes of a packaging taped imbricated bag chain

2005210142-Method for producing conjugates of polysaccharides and polynucleotides